financetom
Business
financetom
/
Business
/
Italy regulator launches probe into Booking.com for potential abuse of dominant position
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Italy regulator launches probe into Booking.com for potential abuse of dominant position
Mar 22, 2024 2:51 AM

ROME, March 22 (Reuters) - Italy's antitrust has opened

a probe into Booking.com to establish whether the

travel website is in a potential abuse of dominant position, the

regulator said on Friday.

The watchdog said that the website's handling of the hotels

that are part of its Preferred Partner Programme "seems likely

to hinder effective competition in the market, at least

nationwide, for online hotel brokerage and reservation

services".

This strategy is "to the detriment of other online travel

agents with negative effects on accommodation facilities and,

ultimately, on consumers in terms of higher prices and less

choice.", the authority said in a statement adding that it had

carried out inspection in the Italian offices of the company.

Booking.com was not immediately available for comment.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Boardwalk REIT Provides Operational Update
Boardwalk REIT Provides Operational Update
Oct 3, 2024
08:50 AM EDT, 10/03/2024 (MT Newswires) -- Boardwalk REIT (BEI-UN.TO) on Thursday said its operations show the continued strong demand for affordable rental housing. Its average occupied rent of $1,485 per month for August, was 36% below the Canadian average listing rent of $2,310 for a two-bedroom apartment unit. Edmonton, the Trust's largest market, has an average listing rent for...
Spectral Medical Provides Updates on Tigris Trial; Completion Expected by Yearend
Spectral Medical Provides Updates on Tigris Trial; Completion Expected by Yearend
Oct 3, 2024
08:47 AM EDT, 10/03/2024 (MT Newswires) -- Spectral Medical ( EDTXF ) , a theranostic company advancing therapeutic options for sepsis and septic shock, on Thursday provided an update on its Tigris trial, a phase 3 follow-on study evaluating the use of Polymyxin B Hemoperfusion in a randomized controlled trial of adults treated for endotoxemia and septic shock. The company...
Sector Update: Consumer
Sector Update: Consumer
Oct 3, 2024
08:50 AM EDT, 10/03/2024 (MT Newswires) -- Consumer stocks were mixed pre-bell Thursday with the Consumer Staples Select Sector SPDR Fund (XLP) 0.3% higher and the Consumer Discretionary Select Sector SPDR Fund (XLY) down 0.4%. Levi Strauss (LEVI) shares fell by over 11% after the company reported a fiscal Q3 net revenue that missed the average analyst estimate compiled by...
Update: Eli Lilly's Tirzepatide Injection No Longer in Shortage in US, FDA Says
Update: Eli Lilly's Tirzepatide Injection No Longer in Shortage in US, FDA Says
Oct 3, 2024
08:49 AM EDT, 10/03/2024 (MT Newswires) -- (Updates with Eli Lilly's ( LLY ) response in the last two paragraphs.) Eli Lilly's ( LLY ) tirzepatide injection is no longer considered to be in short supply in the US, the US Food and Drug Administration said in a notice Wednesday. Tirzepatide injection had been in shortage since 2022 due to...
Copyright 2023-2026 - www.financetom.com All Rights Reserved